PHASE II Comprehensive ICOHRTA AIDS/TB (U2R)

The summary for the PHASE II Comprehensive ICOHRTA AIDS/TB (U2R) Federal Grant is detailed below. It contains information such as the Catalog of Federal Domestic Assistance (CFDA) number, who is eligible for the grant, how much grant money will be awarded, important deadlines, and a sampling of similar government grants. Verify the accuracy of the data FederalGrants.com provides by visiting the webpage noted in the Link to Full Announcement section or by contacting the appropriate person listed in the Grant Announcement Contact section. If these sections are incomplete, please visit the website of the government agency that is offering this grant.


	Federal Grant Title:	PHASE II Comprehensive ICOHRTA AIDS/TB (U2R)
	CFDA Number:	93.279
	CFDA Description:	Drug Abuse and Addiction Research Programs
	Federal Agency Name:	National Institutes of Health
	Category of Funding Activity:	Education Health Income Security and Social Services
	Category Explanation:	Information not provided
	Opportunity Category:	Discretionary
	Funding Opportunity Number:	PAR-08-155
	Document Type:	Grants Notice
	Funding Instrument Type:	Cooperative Agreement
	Posted Date:	Dec 02, 2008
	Creation Date:	Dec 02, 2008
	Original Closing Date for Applications:	Aug 18, 2009
	Current Closing Date for Applications:	Aug 18, 2009
	Archive Date:	Sep 18, 2009
	Expected Number of Awards:	Information not provided
	Estimated Total Program Funding:	$3,000,000
	Federal Grant Award Ceiling:	$275,000
	Federal Grant Award Floor:	Information not provided
	Cost Sharing or Matching Requirement:	No

Applicants Eligible for this Grant: Public and State controlled institutions of higher education - Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education - Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education - Private institutions of higher education - Others (see text field entitled "Additional Information on Eligibility" for clarification)
Additional Information on Eligibility: Other Eligible Applicants include the following: Alaska Native and Native Hawaiian Serving Institutions; Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Non-domestic (non-U.S.) Entities (Foreign Organizations); Tribally Controlled Colleges and Universities (TCCUs) ; New applications for a Phase II Comprehensive ICOHRTA-AIDS/TB Award will only be accepted from foreign institutions that were awarded a planning grant under Phase I ICOHRTA AIDS TB program announcement and the U.S. non-profit partner institution that the planning grant recipient has chosen. The foreign and U.S. partner applicant institutions must have achieved a strong record of receiving or being significantly involved in HIV/AIDS and/or TB international research. Both the foreign and U.S. partner institutions must demonstrate the capacity and leadership necessary for the successful implementation and long-term productivity of the program. Renewal applications will only be accepted from existing ICOHRTA AIDS TB recipients. Any changes in applicant institutions for U.S. partners need to be well justified.
Grant Description: -Purpose. This Funding Opportunity Announcement (FOA), PAR-08-155, issued by FIC, NIMH, ORWH, and NIDA, NIH solicits renewal (re-competing) and new Phase II applications in the International Clinical, Operations and Health Services Research Training Award for AIDS and TB (ICOHRTA AIDS TB) program. The applications from a Research Training Unit , composed of a Phase I ICOHRTA AIDS TB (planning grant) recipient and the U.S. partner institution chosen by the Phase I recipient, must propose, in an integrated manner, a comprehensive training program that will strengthen the capacity in the foreign country to conduct clinical research and implementation science, including operations and health services research focused on HIV infection, TB, and, where relevant, HIV/TB co-infection prevention, care and treatment. -Mechanism of Support. This FOA will utilize the International Training Cooperative Agreement (U2R) grant mechanism -Funds Available and Anticipated Number of Awards The estimated amount of funds available for support of five-six new or renewal Research Training Units awarded as a result of this announcement is $3,000,000 for fiscal year 2009. Future year amounts will depend on annual appropriations. Facilities and administrative costs are limited to 8% for all awards and sub-awards. The earliest anticipated start dates for awards are April 1, 2009.
Link to Full Grant Announcement: http://grants.nih.gov/grants/guide/pa-files/par-08-155.html
Grant Announcement Contact: NIH OER WebmasterFBOWebmaster@OD.NIH.GOV
If you have any problems linking to this funding announcement, please contact the NIH OER Webmaster [FBOWebmaster@OD.NIH.GOV]
Similar Government Grants: • FY12 NIDA Avant-Garde Award Program for HIV/AIDS Research (DP1); • Pre-Application for the FY12 NIDA Avant-Garde Award Program for HIV/AIDS Research (X02); • Pre-Application for the 2012 NIDA Translational Avant-Garde Award for Medication Development for the...; • 2012 NIDA Translational Avant-Garde Award for Medication Development for the Treatment of Substance ...; • International Tobacco and Health Research and Capacity Building Program (R01); • NIDA Phase II Small Business Innovation Research (SBIR [R44]) Competing Renewal Awards; • DRUG ABUSE ASPECTS OF HIV/AIDS AND OTHER INFECTIONS; • EPIDEMIOLOGY OF DRUG ABUSE; • PRESCRIPTION DRUG ABUSE; • MDMA: RESEARCH AREAS NEEDING MORE EMPHASIS